GrafTech Reports Third Quarter 2024 Results
Delivering on Outlook and Successfully Executing Strategic Initiatives to Reduce Costs
Announcing Agreement for New Capital to Bolster Liquidity
Third Quarter 2024 Summary
- Exceeded cost reduction goals resulting in significant cost improvement
- Generated positive cash flow through working capital and capital expenditure management
- Grew sales volume 9% year-over-year to 26.4 thousand metric tons ("MT")
- Achieved third consecutive quarter of sequential sales volume growth
- Announced financing agreement that will increase liquidity and extend debt maturities
-
Net sales of
$131 million -
Net loss of
$36 million , or$0.14 per share(1) -
Adjusted EBITDA(2) of negative
$6 million -
Net cash provided by operating activities of
$24 million -
Adjusted free cash flow(2) of
$20 million
Summary of Transactions for New Capital
The transactions for new capital (collectively, the "Transactions"), which are expected to close during the fourth quarter of 2024, will provide incremental liquidity and extend our current debt maturities as we manage the near-term industry-wide challenges. Key terms of the Commitment Letter include the following:
-
$175 million of new senior first lien term loans, funded at transaction closing. -
Commitments to fund an additional
$100 million of new senior first lien term loans, which are available to be drawn for 19 months following transaction closing. -
New senior term loans, both initially funded and subject to delayed draw, will bear interest at a variable rate of SOFR plus 600 basis points and will mature in
December 2029 . -
An exchange offer will be launched for all of the Company’s outstanding
$950 million senior secured notes dueDecember 2028 for new second lien notes dueDecember 2029 . -
The Company’s existing
$330 million senior secured revolving credit facility maturing inMay 2027 will be replaced with up to$225 million of new first lien revolving commitments maturing inNovember 2028 . - The Transactions are subject to the satisfaction or waiver of a number of customary closing conditions.
CEO Comments
"We grew volume, cut costs and generated positive cash flow in the third quarter and we are capitalizing on an opportunity to improve our liquidity position," said
"Furthermore, our announced financing agreement will provide
Third Quarter 2024 Financial Performance |
|||||||||||||||||||
(dollars in thousands, except per share amounts) |
|
|
Nine Months Ended |
||||||||||||||||
|
|
|
|||||||||||||||||
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
|
2024 |
|
|
|
2023 |
|
|||||||
Net sales |
$ |
130,654 |
|
$ |
137,327 |
|
$ |
158,992 |
|
|
$ |
404,565 |
|
$ |
483,355 |
|
|||
Net loss |
$ |
(36,068 |
) |
$ |
(14,752 |
) |
$ |
(22,621 |
) |
|
$ |
(81,689 |
) |
$ |
(37,841 |
) |
|||
Loss per share(1) |
$ |
(0.14 |
) |
$ |
(0.06 |
) |
$ |
(0.09 |
) |
|
$ |
(0.32 |
) |
$ |
(0.15 |
) |
|||
Net cash provided by (used in) operating activities |
$ |
23,709 |
|
$ |
(36,855 |
) |
$ |
51,495 |
|
|
$ |
(13,676 |
) |
$ |
67,269 |
|
|||
|
|
|
|
|
|
|
|||||||||||||
Adjusted net loss(2) |
$ |
(34,276 |
) |
$ |
(13,564 |
) |
$ |
(20,866 |
) |
|
$ |
(73,001 |
) |
$ |
(32,183 |
) |
|||
Adjusted loss per share(1)(2) |
$ |
(0.13 |
) |
$ |
(0.05 |
) |
$ |
(0.08 |
) |
|
$ |
(0.28 |
) |
$ |
(0.13 |
) |
|||
Adjusted EBITDA(2) |
$ |
(6,196 |
) |
$ |
14,493 |
|
$ |
919 |
|
|
$ |
8,491 |
|
$ |
42,056 |
|
|||
Adjusted free cash flow(2) |
$ |
19,682 |
|
$ |
(43,834 |
) |
$ |
42,997 |
|
|
$ |
(35,193 |
) |
$ |
46,435 |
|
|||
Net sales for the third quarter of 2024 were
Net loss for the third quarter of 2024 was
Adjusted EBITDA(2) was negative
In the third quarter of 2024, net cash provided by operating activities was
Operational and Commercial Update |
||||||||||||||
Key Operating Metrics |
|
|
|
|
|
|
Nine Months Ended |
|||||||
|
|
|
|
|
|
|
|
|||||||
(in thousands, except percentages) |
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
2024 |
|
2023 |
|||||
Sales volume (MT) |
26.4 |
|
25.5 |
|
24.2 |
|
|
76.0 |
|
67.5 |
|
|||
Production volume (MT)(3) |
19.4 |
|
26.8 |
|
22.7 |
|
|
72.2 |
|
63.7 |
|
|||
Production capacity (MT)(4)(5) |
42.0 |
|
45.0 |
|
48.0 |
|
|
132.0 |
|
150.0 |
|
|||
Capacity utilization(6) |
46 |
% |
60 |
% |
47 |
% |
|
55 |
% |
42 |
% |
|||
Sales volume for the third quarter of 2024 was 26.4 thousand MT, consisting of 23.4 thousand MT of non-LTA volume and 3.0 thousand MT of LTA volume, and increased 9% compared to the third quarter of 2023.
For the third quarter of 2024, the weighted-average realized price for our non-LTA volume was approximately
Production volume was 19.4 thousand MT in the third quarter of 2024, a decrease of 15% compared to the third quarter of 2023. The decline primarily reflected extended production shutdowns at our European graphite electrode manufacturing facilities during the third quarter of 2024, as was planned.
The table of estimated shipments of graphite electrodes under existing LTAs is as follows, reflecting our current expectations for the full year 2024:
|
|
2024 |
|
Estimated LTA volume (in thousands of MT) |
|
13 - 14 |
|
Estimated LTA revenue (in millions) |
|
|
Capital Structure and Liquidity
As of
Outlook
We expect demand for graphite electrodes in the near term will remain weak, reflecting persistent challenges in the commercial environment as steel industry production remains constrained by global economic uncertainty. Given these trends, challenging pricing dynamics have persisted in most regions. As a result, we remain selective in the commercial opportunities we choose to pursue. Despite these headwinds, we expect a low double-digit percentage point year-over-year improvement in sales volume for the full year of 2024. Sales volume in the fourth quarter of 2024 is expected to be broadly in line with sales volume for the third quarter of 2024. For 2025, we expect another year of low double-digit percentage point sales volume growth. This performance reflects our compelling customer value proposition and our ongoing focus on delivering on the needs of our customers.
As it relates to costs, we now expect the year-over-year decline in our full-year 2024 cash cost of goods sold per MT to exceed our previous guidance of a mid-teen percentage point decline compared to 2023. Reflecting the continued progress we are making on our cost structure, we now anticipate a decline of approximately 20% for the full year of 2024, compared to 2023, and we anticipate a further improvement in 2025. The significant improvement in our cost structure reflects (1) the deliberate actions we have taken to reduce our fixed manufacturing costs, (2) the benefit of additional actions we are taking to reduce our variable costs and (3) the anticipated year-over-year improvement in our sales and production volume levels.
In addition, we continue to closely manage our working capital levels and capital expenditures. For 2024, we now expect the net impact of working capital will be favorable to our full-year cash flow performance. We continue to anticipate our full-year 2024 capital expenditures will be in the range of
Longer term, we remain confident that the steel industry’s accelerating efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We also anticipate the demand for petroleum needle coke, the key raw material we use to produce graphite electrodes, to accelerate driven by its utilization in producing synthetic graphite for use in lithium-ion batteries for the growing electric vehicle market. We believe that the near-term actions we are taking, supported by an industry-leading position and our sustainable competitive advantages, including our substantial vertical integration into petroleum needle coke via our Seadrift facility, will optimally position
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings call being held on
About
________________________ |
|
(1) |
Loss per share represents diluted loss per share. Adjusted loss per share represents diluted adjusted loss per share. |
(2) |
A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
(3) |
Production volume reflects graphite electrodes we produced during the period. |
(4) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
(5) |
Includes graphite electrode facilities in Calais, |
(6) |
Capacity utilization reflects production volume as a percentage of production capacity. |
(7) |
Estimated LTA revenue includes payments from customers that failed to meet certain obligations under their LTAs. |
(8) |
Gross debt reflects the notional value of our outstanding debt and excludes unamortized debt discount and issuance costs. |
(9) |
A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents ( |
Cautionary Note Regarding Forward-Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our most recent Annual Report on Form 10-K and other filings with the
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Non-GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted net loss, adjusted loss per share, free cash flow, adjusted free cash flow, net debt and cash cost of goods sold per MT are non-GAAP financial measures.
We define EBITDA, a non-GAAP financial measure, as net loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA, a non-GAAP financial measure, as EBITDA adjusted by any pension and other post-employment benefit ("OPEB") plan expenses or benefits, rationalization and rationalization-related expenses, non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period-to-period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt-service capabilities.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses or benefits relating to our pension and OPEB plans;
- adjusted EBITDA does not reflect rationalization or rationalization-related expenses;
-
adjusted EBITDA does not reflect the non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar; - adjusted EBITDA does not reflect stock-based compensation expense;
- adjusted EBITDA does not reflect proxy contest expenses;
- adjusted EBITDA does not reflect Tax Receivable Agreement adjustments; and
- other companies, including companies in our industry, may calculate EBITDA and adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
We define adjusted net loss, a non-GAAP financial measure, as net loss, excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted loss per share, a non-GAAP financial measure, as adjusted net loss divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net loss and adjusted loss per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
We define free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less capital expenditures. We define adjusted free cash flow, a non-GAAP financial measure, as free cash flow adjusted by payments made or received from the settlement of interest rate swap contracts. We use free cash flow and adjusted free cash flow as critical measures in the evaluation of liquidity in conjunction with related GAAP amounts. We also use these measures when considering available cash, including for decision-making purposes related to dividends and discretionary investments. Further, these measures help management, the audit committee, and investors evaluate the Company's ability to generate liquidity from operating activities.
We define net debt, a non-GAAP financial measure, as gross debt minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.
We define cash cost of goods sold per MT, a non-GAAP financial measure, as cost of goods sold less depreciation and amortization, less cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes and less rationalization-related expenses, with this total divided by our sales volume measured in MT. We believe this is an important measure as it is used by our management and Board of Directors to evaluate our costs on a per MT basis.
In evaluating these non-GAAP financial measures, you should be aware that in the future, we may incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of these non-GAAP financial measures should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider these non-GAAP financial measures alongside other measures of financial performance and liquidity, including our net loss, loss per share, cash flow from operating activities, cost of goods sold and other GAAP measures.
|
|||||||
|
2024 |
|
2023 |
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
141,406 |
|
|
$ |
176,878 |
|
Accounts and notes receivable, net of allowance for doubtful accounts of |
|
89,516 |
|
|
|
101,387 |
|
Inventories |
|
266,459 |
|
|
|
330,146 |
|
Prepaid expenses and other current assets |
|
60,611 |
|
|
|
66,382 |
|
Total current assets |
|
557,992 |
|
|
|
674,793 |
|
Property, plant and equipment |
|
933,502 |
|
|
|
920,444 |
|
Less: accumulated depreciation |
|
436,815 |
|
|
|
398,330 |
|
Net property, plant and equipment |
|
496,687 |
|
|
|
522,114 |
|
Deferred income taxes |
|
36,599 |
|
|
|
31,542 |
|
Other assets |
|
51,720 |
|
|
|
60,440 |
|
Total assets |
$ |
1,142,998 |
|
|
$ |
1,288,889 |
|
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
55,112 |
|
|
$ |
83,268 |
|
Long-term debt, current maturities |
|
139 |
|
|
|
134 |
|
Accrued income and other taxes |
|
10,085 |
|
|
|
10,022 |
|
Other accrued liabilities |
|
79,906 |
|
|
|
91,702 |
|
Tax Receivable Agreement |
|
1,949 |
|
|
|
5,417 |
|
Total current liabilities |
|
147,191 |
|
|
|
190,543 |
|
|
|
|
|
||||
Long-term debt |
|
929,313 |
|
|
|
925,511 |
|
Other long-term obligations |
|
47,760 |
|
|
|
55,645 |
|
Deferred income taxes |
|
23,944 |
|
|
|
33,206 |
|
Tax Receivable Agreement long-term |
|
3,788 |
|
|
|
5,737 |
|
Stockholders’ (deficit) equity: |
|
|
|
||||
Preferred stock, par value |
|
— |
|
|
|
— |
|
Common stock, par value |
|
2,572 |
|
|
|
2,568 |
|
Additional paid-in capital |
|
753,796 |
|
|
|
749,527 |
|
Accumulated other comprehensive loss |
|
(21,378 |
) |
|
|
(11,458 |
) |
Accumulated deficit |
|
(743,988 |
) |
|
|
(662,390 |
) |
Total stockholders’ (deficit) equity |
|
(8,998 |
) |
|
|
78,247 |
|
Total liabilities and stockholders’ (deficit) equity |
$ |
1,142,998 |
|
|
$ |
1,288,889 |
|
|
|||||||||||||||
|
Three Months Ended S eptember 30, |
|
Nine Months Ended S eptember 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
||||||||
Net sales |
$ |
130,654 |
|
|
$ |
158,992 |
|
|
$ |
404,565 |
|
|
$ |
483,355 |
|
Cost of goods sold |
|
134,885 |
|
|
|
157,603 |
|
|
|
402,059 |
|
|
|
427,464 |
|
Lower of cost or market inventory valuation adjustment |
|
7,843 |
|
|
|
— |
|
|
|
11,916 |
|
|
|
— |
|
Gross (loss) profit |
|
(12,074 |
) |
|
|
1,389 |
|
|
|
(9,410 |
) |
|
|
55,891 |
|
Research and development |
|
1,245 |
|
|
|
1,295 |
|
|
|
4,319 |
|
|
|
3,683 |
|
Selling and administrative expenses |
|
13,060 |
|
|
|
18,231 |
|
|
|
33,435 |
|
|
|
58,933 |
|
Rationalization expenses |
|
(99 |
) |
|
|
— |
|
|
|
3,156 |
|
|
|
— |
|
Operating loss |
|
(26,280 |
) |
|
|
(18,137 |
) |
|
|
(50,320 |
) |
|
|
(6,725 |
) |
|
|
|
|
|
|
|
|
||||||||
Other (income) expense, net |
|
(285 |
) |
|
|
153 |
|
|
|
(1,769 |
) |
|
|
1,261 |
|
Interest expense |
|
16,503 |
|
|
|
15,719 |
|
|
|
47,738 |
|
|
|
42,432 |
|
Interest income |
|
(1,098 |
) |
|
|
(1,144 |
) |
|
|
(4,475 |
) |
|
|
(1,758 |
) |
Loss before income taxes |
|
(41,400 |
) |
|
|
(32,865 |
) |
|
|
(91,814 |
) |
|
|
(48,660 |
) |
Income tax benefit |
|
(5,332 |
) |
|
|
(10,244 |
) |
|
|
(10,125 |
) |
|
|
(10,819 |
) |
Net loss |
$ |
(36,068 |
) |
|
$ |
(22,621 |
) |
|
$ |
(81,689 |
) |
|
$ |
(37,841 |
) |
|
|
|
|
|
|
|
|
||||||||
Basic loss per common share: |
|
|
|
|
|
|
|
||||||||
Net loss per share |
$ |
(0.14 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.32 |
) |
|
$ |
(0.15 |
) |
Weighted average common shares outstanding |
|
257,694,799 |
|
|
|
257,090,113 |
|
|
|
257,568,237 |
|
|
|
256,987,778 |
|
Diluted loss per common share: |
|
|
|
|
|
|
|
||||||||
Net loss per share |
$ |
(0.14 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.32 |
) |
|
$ |
(0.15 |
) |
Weighted average common shares outstanding |
|
257,694,799 |
|
|
|
257,090,113 |
|
|
|
257,568,237 |
|
|
|
256,987,778 |
|
|
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Cash flow from operating activities: |
|
|
|
|
|
|
|
||||||||
Net loss |
$ |
(36,068 |
) |
|
$ |
(22,621 |
) |
|
$ |
(81,689 |
) |
|
$ |
(37,841 |
) |
Adjustments to reconcile net loss to cash provided by (used in) operations: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
17,933 |
|
|
|
16,954 |
|
|
|
46,135 |
|
|
|
43,053 |
|
Deferred income tax benefit |
|
(5,625 |
) |
|
|
(3,873 |
) |
|
|
(11,743 |
) |
|
|
(10,297 |
) |
Non-cash stock-based compensation expense |
|
1,838 |
|
|
|
1,628 |
|
|
|
4,446 |
|
|
|
3,809 |
|
Non-cash interest expense |
|
(608 |
) |
|
|
(1,435 |
) |
|
|
(3,578 |
) |
|
|
10,249 |
|
Lower of cost or market inventory valuation adjustment |
|
7,843 |
|
|
|
— |
|
|
|
11,916 |
|
|
|
— |
|
Other adjustments |
|
2,742 |
|
|
|
3,138 |
|
|
|
4,981 |
|
|
|
(3,278 |
) |
Net change in working capital* |
|
43,056 |
|
|
|
58,433 |
|
|
|
29,711 |
|
|
|
64,833 |
|
Change in Tax Receivable Agreement |
|
— |
|
|
|
— |
|
|
|
(5,417 |
) |
|
|
(4,631 |
) |
Change in long-term assets and liabilities |
|
(7,402 |
) |
|
|
(729 |
) |
|
|
(8,438 |
) |
|
|
1,372 |
|
Net cash provided by (used in) operating activities |
|
23,709 |
|
|
|
51,495 |
|
|
|
(13,676 |
) |
|
|
67,269 |
|
Cash flow from investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures |
|
(4,027 |
) |
|
|
(8,498 |
) |
|
|
(21,517 |
) |
|
|
(48,287 |
) |
Proceeds from the sale of fixed assets |
|
20 |
|
|
|
6 |
|
|
|
100 |
|
|
|
220 |
|
Net cash used in investing activities |
|
(4,007 |
) |
|
|
(8,492 |
) |
|
|
(21,417 |
) |
|
|
(48,067 |
) |
Cash flow from financing activities: |
|
|
|
|
|
|
|
||||||||
Interest rate swap settlements |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
27,453 |
|
Debt issuance and modification costs |
|
— |
|
|
|
(1,809 |
) |
|
|
— |
|
|
|
(8,133 |
) |
Proceeds from the issuance of long-term debt, net of original issuance discount |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
438,552 |
|
Principal payments on long-term debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(433,708 |
) |
Payments for taxes related to net share settlement of equity awards |
|
— |
|
|
|
— |
|
|
|
(82 |
) |
|
|
(129 |
) |
Dividends paid |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,134 |
) |
Principal payments under finance lease obligations |
|
(23 |
) |
|
|
(10 |
) |
|
|
(58 |
) |
|
|
(20 |
) |
Net cash (used in) provided by financing activities |
|
(23 |
) |
|
|
(1,819 |
) |
|
|
(140 |
) |
|
|
18,881 |
|
Net change in cash and cash equivalents |
|
19,679 |
|
|
|
41,184 |
|
|
|
(35,233 |
) |
|
|
38,083 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
1,001 |
|
|
|
(537 |
) |
|
|
(239 |
) |
|
|
83 |
|
Cash and cash equivalents at beginning of period |
|
120,726 |
|
|
|
132,160 |
|
|
|
176,878 |
|
|
|
134,641 |
|
Cash and cash equivalents at end of period |
$ |
141,406 |
|
|
$ |
172,807 |
|
|
$ |
141,406 |
|
|
$ |
172,807 |
|
|
|
|
|
|
|
|
|
||||||||
* Net change in working capital due to changes in the following components: |
|
|
|
|
|
|
|||||||||
Accounts and notes receivable, net |
$ |
6,759 |
|
|
$ |
13,287 |
|
|
$ |
11,201 |
|
|
$ |
48,007 |
|
Inventories |
|
29,319 |
|
|
|
50,526 |
|
|
|
50,105 |
|
|
|
69,258 |
|
Prepaid expenses and other current assets |
|
2,093 |
|
|
|
841 |
|
|
|
2,810 |
|
|
|
4,974 |
|
Income taxes payable |
|
248 |
|
|
|
(8,960 |
) |
|
|
(2,616 |
) |
|
|
(31,356 |
) |
Accounts payable and accruals |
|
(12,254 |
) |
|
|
(14,250 |
) |
|
|
(48,666 |
) |
|
|
(43,391 |
) |
Interest payable |
|
16,891 |
|
|
|
16,989 |
|
|
|
16,877 |
|
|
|
17,341 |
|
Net change in working capital |
$ |
43,056 |
|
|
$ |
58,433 |
|
|
$ |
29,711 |
|
|
$ |
64,833 |
|
NON-GAAP RECONCILIATIONS
|
|||||||||||||||||||
Reconciliation of Net Loss to Adjusted Net Loss |
|
||||||||||||||||||
|
|
|
|
|
|
|
Nine Months Ended
|
||||||||||||
|
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
|
2024 |
|
|
|
2023 |
|
||||||
|
|
|
|
|
|
||||||||||||||
Net loss |
$ |
(36,068 |
) |
$ |
(14,752 |
) |
$ |
(22,621 |
) |
$ |
(81,689 |
) |
$ |
(37,841 |
) |
||||
|
|
|
|
|
|
||||||||||||||
Diluted loss per common share: |
|
|
|
|
|
||||||||||||||
Net loss per share |
$ |
(0.14 |
) |
$ |
(0.06 |
) |
$ |
(0.09 |
) |
$ |
(0.32 |
) |
$ |
(0.15 |
) |
||||
Weighted average shares outstanding |
|
257,694,799 |
|
|
257,772,069 |
|
|
257,090,113 |
|
|
257,568,237 |
|
|
256,987,778 |
|
||||
|
|
|
|
|
|
||||||||||||||
Adjustments, pre-tax: |
|
|
|
|
|
||||||||||||||
Pension and OPEB plan expenses(1) |
|
479 |
|
|
477 |
|
|
914 |
|
|
1,303 |
|
|
2,731 |
|
||||
Rationalization expenses(2) |
|
(99 |
) |
|
110 |
|
|
— |
|
|
3,156 |
|
|
— |
|
||||
Rationalization-related expenses(3) |
|
— |
|
|
— |
|
|
— |
|
|
2,655 |
|
|
— |
|
||||
Non-cash (gains) losses on foreign currency remeasurement(4) |
|
(352 |
) |
|
(928 |
) |
|
(287 |
) |
|
(1,442 |
) |
|
433 |
|
||||
Stock-based compensation expense(5) |
|
1,838 |
|
|
1,561 |
|
|
1,628 |
|
|
4,446 |
|
|
3,809 |
|
||||
Proxy contest expenses(6) |
|
— |
|
|
542 |
|
|
— |
|
|
752 |
|
|
— |
|
||||
Tax Receivable Agreement adjustment(7) |
|
— |
|
|
— |
|
|
— |
|
|
37 |
|
|
16 |
|
||||
Total non-GAAP adjustments pre-tax |
|
1,866 |
|
|
1,762 |
|
|
2,255 |
|
|
10,907 |
|
|
6,989 |
|
||||
Income tax impact on non-GAAP adjustments(8) |
|
74 |
|
|
574 |
|
|
500 |
|
|
2,219 |
|
|
1,331 |
|
||||
Adjusted net loss |
$ |
(34,276 |
) |
$ |
(13,564 |
) |
$ |
(20,866 |
) |
$ |
(73,001 |
) |
$ |
(32,183 |
) |
Reconciliation of Loss Per Share to Adjusted Loss Per Share |
|||||||||||||||||||
|
|
|
|
|
|
|
Nine Months Ended S eptember 30, |
||||||||||||
|
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
|
2024 |
|
|
|
2023 |
|
||||||
|
|
|
|
|
|
||||||||||||||
Loss per share |
$ |
(0.14 |
) |
$ |
(0.06 |
) |
$ |
(0.09 |
) |
$ |
(0.32 |
) |
$ |
(0.15 |
) |
||||
Adjustments per share: |
|
|
|
|
|
||||||||||||||
Pension and OPEB plan expenses(1) |
|
— |
|
|
— |
|
|
— |
|
|
0.01 |
|
|
0.01 |
|
||||
Rationalization expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
0.01 |
|
|
— |
|
||||
Rationalization-related expenses(3) |
|
— |
|
|
— |
|
|
— |
|
|
0.01 |
|
|
— |
|
||||
Non-cash (gains) losses on foreign currency remeasurement(4) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||
Stock-based compensation expense(5) |
|
0.01 |
|
|
0.01 |
|
|
0.01 |
|
|
0.02 |
|
|
0.02 |
|
||||
Proxy contest expenses(6) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||
Tax Receivable Agreement adjustment(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||
Total non-GAAP adjustments pre-tax per share |
|
0.01 |
|
|
0.01 |
|
|
0.01 |
|
|
0.05 |
|
|
0.03 |
|
||||
Income tax impact on non-GAAP adjustments per share(8) |
|
— |
|
|
— |
|
|
— |
|
|
0.01 |
|
|
0.01 |
|
||||
Adjusted loss per share |
$ |
(0.13 |
) |
$ |
(0.05 |
) |
$ |
(0.08 |
) |
$ |
(0.28 |
) |
$ |
(0.13 |
) |
Reconciliation of Net Loss to Adjusted EBITDA |
|||||||||||||||||||
|
|
|
|
|
|
|
Nine Months Ended S eptember 30, |
||||||||||||
|
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
|
2024 |
|
|
|
2023 |
|
||||||
|
|
|
|
|
|
||||||||||||||
Net loss |
$ |
(36,068 |
) |
$ |
(14,752 |
) |
$ |
(22,621 |
) |
$ |
(81,689 |
) |
$ |
(37,841 |
) |
||||
Add: |
|
|
|
|
|
||||||||||||||
Depreciation and amortization |
|
17,933 |
|
|
14,319 |
|
|
16,954 |
|
|
46,135 |
|
|
43,053 |
|
||||
Interest expense |
|
16,503 |
|
|
15,609 |
|
|
15,719 |
|
|
47,738 |
|
|
42,432 |
|
||||
Interest income |
|
(1,098 |
) |
|
(1,853 |
) |
|
(1,144 |
) |
|
(4,475 |
) |
|
(1,758 |
) |
||||
Income taxes |
|
(5,332 |
) |
|
(592 |
) |
|
(10,244 |
) |
|
(10,125 |
) |
|
(10,819 |
) |
||||
EBITDA |
|
(8,062 |
) |
|
12,731 |
|
|
(1,336 |
) |
|
(2,416 |
) |
|
35,067 |
|
||||
Adjustments: |
|
|
|
|
|
||||||||||||||
Pension and OPEB plan expenses(1) |
|
479 |
|
|
477 |
|
|
914 |
|
|
1,303 |
|
|
2,731 |
|
||||
Rationalization expenses(2) |
|
(99 |
) |
|
110 |
|
|
— |
|
|
3,156 |
|
|
— |
|
||||
Rationalization-related expenses(3) |
|
— |
|
|
— |
|
|
— |
|
|
2,655 |
|
|
— |
|
||||
Non-cash (gains) losses on foreign currency remeasurement(4) |
|
(352 |
) |
|
(928 |
) |
|
(287 |
) |
|
(1,442 |
) |
|
433 |
|
||||
Stock-based compensation expense(5) |
|
1,838 |
|
|
1,561 |
|
|
1,628 |
|
|
4,446 |
|
|
3,809 |
|
||||
Proxy contest expenses(6) |
|
— |
|
|
542 |
|
|
— |
|
|
752 |
|
|
— |
|
||||
Tax Receivable Agreement adjustment(7) |
|
— |
|
|
— |
|
|
— |
|
|
37 |
|
|
16 |
|
||||
Adjusted EBITDA |
$ |
(6,196 |
) |
$ |
14,493 |
|
$ |
919 |
|
$ |
8,491 |
|
$ |
42,056 |
|
Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Adjusted Free Cash Flow |
|||||||||||||||||||
|
|
|
|
|
|
|
Nine Months Ended S eptember 30, |
||||||||||||
|
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
|
2024 |
|
|
|
2023 |
|
||||||
|
|
|
|
|
|
||||||||||||||
Net cash provided by (used in) operating activities |
$ |
23,709 |
|
$ |
(36,855 |
) |
$ |
51,495 |
|
$ |
(13,676 |
) |
$ |
67,269 |
|
||||
Capital expenditures |
|
(4,027 |
) |
|
(6,979 |
) |
|
(8,498 |
) |
|
(21,517 |
) |
|
(48,287 |
) |
||||
Free cash flow |
|
19,682 |
|
|
(43,834 |
) |
|
42,997 |
|
|
(35,193 |
) |
|
18,982 |
|
||||
|
|
|
|
|
|
||||||||||||||
Interest rate swap settlements(9) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
27,453 |
|
||||
Adjusted free cash flow |
$ |
19,682 |
|
$ |
(43,834 |
) |
$ |
42,997 |
|
$ |
(35,193 |
) |
$ |
46,435 |
|
Reconciliation of Cost of Goods Sold to Cash Cost of Goods Sold per MT |
|||||||||||||||||||
|
|
|
|
Nine Months Ended
|
|||||||||||||||
|
Q3 2024 |
|
Q2 2024 |
|
Q3 2023 |
|
2024 |
|
2023 |
||||||||||
|
|
|
|
|
|
||||||||||||||
Cost of goods sold |
$ |
134,885 |
$ |
131,970 |
$ |
157,603 |
$ |
402,059 |
$ |
427,464 |
|||||||||
Less: |
|
|
|
|
|
||||||||||||||
Depreciation and amortization(10) |
|
16,281 |
|
12,648 |
|
15,291 |
|
41,136 |
|
37,961 |
|||||||||
Cost of goods sold - by-products and other(11) |
|
7,806 |
|
9,301 |
|
430 |
|
26,707 |
|
13,720 |
|||||||||
Rationalization-related expenses(3) |
|
— |
|
— |
|
— |
|
2,655 |
|
— |
|||||||||
Cash cost of goods sold |
|
110,798 |
|
110,021 |
|
141,882 |
|
331,561 |
|
375,783 |
|||||||||
Sales volume (in thousands of MT) |
|
26.4 |
|
25.5 |
|
24.2 |
|
76.0 |
|
67.5 |
|||||||||
Cash cost of goods sold per MT |
$ |
4,197 |
$ |
4,315 |
$ |
5,863 |
$ |
4,363 |
$ |
5,567 |
(1) |
Net periodic benefit cost for our pension and OPEB plans. |
(2) |
Severance and contract termination costs associated with the cost rationalization and footprint optimization plan announced in |
(3) |
Other non-cash costs, primarily inventory and fixed asset write-offs, associated with the cost rationalization and footprint optimization plan announced in |
(4) |
Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
(5) |
Non-cash expense for stock-based compensation awards. |
(6) |
Expenses associated with our proxy contest. |
(7) |
Expense adjustment for future payment to our sole pre-initial public offering stockholder for tax assets that have been utilized. |
(8) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
(9) |
Receipt of cash related to the monthly settlement of our interest rate swap contracts prior to their termination in the second quarter of 2023, as well as receipt of cash related to the termination of the interest rate swap contracts. |
(10) |
Reflects the portion of depreciation and amortization that is recognized in cost of goods sold. |
(11) |
Primarily reflects cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111112647/en/
216-676-2000
investor.relations@graftech.com
Source: